Male Health

US FDA grants approval for Orion-Bayer’s Nubeqa combo for prostate cancer

The US Food and Drug Administration (FDA) has granted approval for a supplemental New Drug Application (sNDA) of Orion and its partner Bayer’s…

How close are we to getting a male contraceptive?

With advances in clinical studies evaluating male contraceptives, and laws restricting abortion access after Roe v. Wade was overturned in…

Approach to spur testosterone production instead of synthesis on the horizon

Low testosterone in men is a widespread clinical problem linked to obesity, high blood pressure and Type 2 diabetes. Nearly…

Concerns over safety on fertility are unfounded for Covid-19 vaccines

Achieving herd immunity to Covid-19 has been made difficult by internet disinformation campaigns. One such speculative idea is that Covid-19…

Breaking the taboo: disrupting the fertility sector

Infertility, defined by the World Health Organization as a disease of the reproductive system that results in disability, has long…

Black US men have higher risk of breast cancer than white men

Breast cancer is a malignant tumour that originates in the breast tissue. Most breast cancers are invasive tumours that have…

Reproductive Hormones and Protein Tests on the rise, says GlobalData

Reproductive hormones and protein tests are incredibly important for the pharmaceutical industry. They facilitate the control and regulations of many…

Prostate cancer incidence is increasing in younger populations

Prostate cancer is one of the most common malignancies occurring in men worldwide.  Its diagnosis and screening techniques have been…

Should breast cancer screening become routine in high-risk men?

Male breast cancer is rare but often deadly. The American Cancer Society estimates that 2,670 new cases of invasive breast…

New blood test for prostate cancer may improve screening and diagnosis

In the US, September is recognised as Prostate Cancer Awareness Month and Prostate Health Month. Prostate cancer affects over three…